Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 0 | 0 | 0 | 0 | 9 |
| Gross Profit | N/A | N/A | N/A | N/A | 9 |
| Operating Expenses | 2,514 | 7,081 | 2,339 | 2,216 | 2,224 |
| Operating Income | -2,514 | -7,081 | -2,339 | -2,216 | -2,215 |
| Other Income | 0 | 0 | 0 | 4 | 3 |
| Pre-tax Income | -2,514 | -7,081 | -2,339 | -2,212 | -2,212 |
| Income Tax | N/A | -1,621 | N/A | N/A | N/A |
| Net Income Continuous | -2,514 | -5,460 | -2,339 | -2,212 | -2,212 |
| Net Income | $-2,514 | $-5,460 | $-2,339 | $-2,212 | $-2,212 |
| EPS Basic Total Ops | -6,649.48 | -15,733.14 | -37,165.83 | -19,948.43 | -20,067.17 |
| EPS Basic Continuous Ops | -6,666.24 | -15,758.97 | -18,753.67 | -19,958.54 | -20,111.36 |
| EPS Diluted Total Ops | -6,649.48 | -15,733.14 | -37,165.83 | -19,948.43 | -20,067.17 |
| EPS Diluted Continuous Ops | -6,666.24 | -15,758.97 | -18,753.67 | -19,958.54 | -20,111.36 |
| EBITDA(a) | $-2,498 | $-7,070 | $-2,327 | $-2,203 | $-2,201 |